APA (7th ed.) Citation

ESK, L., LT, W., SCY, S., KN, M., KY, L., KS, C., . . . SK, C. (2025). Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation. Frontiers in public health, 13, 1497399. https://doi.org/10.3389/fpubh.2025.1497399

Chicago Style (17th ed.) Citation

ESK, Lo, et al. "Using Surveillance Data to Evaluate the Effectiveness of Inactivated/mRNA COVID-19 Vaccine Boosters in Preventing Fatal Outcomes Among Severe COVID-19 Cases During the Current Ambit of SARS-CoV-2 XBB and JN.1 Variant Circulation." Frontiers in Public Health 13 (2025): 1497399. https://doi.org/10.3389/fpubh.2025.1497399.

MLA (9th ed.) Citation

ESK, Lo, et al. "Using Surveillance Data to Evaluate the Effectiveness of Inactivated/mRNA COVID-19 Vaccine Boosters in Preventing Fatal Outcomes Among Severe COVID-19 Cases During the Current Ambit of SARS-CoV-2 XBB and JN.1 Variant Circulation." Frontiers in Public Health, vol. 13, 2025, p. 1497399, https://doi.org/10.3389/fpubh.2025.1497399.